iaf awards logo
Mr. DhirendraVikram Singh
Mr. Dhirendra Vikram Singh

Achiever's Success Story

Mr. Dhirendra Vikram Singh is the founder and Managing Director of Genelife Clinical Research, a Phase I-IV CRO

He developed his interest in the field of cancer research and the basic process of drug discovery at Molecular Hematology & Oncology Research Institute, Muenster, Germany. Later he combined this inspiration with his educational skills and drive to do something for India, in India.

That led him in the field of drug development. Working with some of the big Pharma companies he gained substantial experience, ability and the networking to follow his own vision in this business space. He kick-off Genelife Clinical Research in 2010 as a phase III-IV CRO. Within two years Genelife diversified into pre-clinical research. In 2015 Genelife Clinical Research started its Chemistry wing. Observing the growth in Indian Clinical Research market, he ventured an European operation. He incorporated Genelife Clinical Research Lda in 2019. 

In his development journey of 18 years, his skills and talents have grown with the experiences in clinical research, project management, new business planning, risk reduction techniques, business development and related consulting. A journey was initiated as a Project Coordinator and Project Consultant has reached to Foundering Director with vast knowledge base in areas such as project feasibility, project management, data management, business & marketing strategies, market research for pre-establishment and time management of clinical trials. His ability to deliver is demonstrated by Genelife Clinical research growth from a start-up to a respected midsize Global Clinical Research Organization, which is recognized for its innovative approach towards delivering business value and its commitment to sustainability.

Scroll to Top
Make payment in favour of:  
Account No.: 


Bank Name: Kotak Mahindra Bank
Branch: Mayur Vihar-I, Delhi -110091

IFSC CODE :  KKBK0000203
MICR No.: 110485046


If you are choosing this payment option, then please select and copy the above text before closing this pop-up.